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Background: In the United States, influenza vaccination is recommended for all children 6 months and older;
however, vaccination rates are below target levels. A broad sample of U.S. pediatric offices was assessed to
determine factors that influence in-office influenza vaccination rates.
Methods: Offices (N = 174) were recruited to participate in an observational study over three influenza seasons
(2008–2009, 2009–2010, 2010–2011). Only data from the first year of an office’s participation in the study were used.
Associations of coverage and 2-dose compliance rates with office characteristics and selected vaccination activities
were examined using univariate regression analyses and linear regression analyses using office characteristics
identified a priori and vaccination activities with P values ≤0.10 in univariate analyses.
Results: Influenza vaccination coverage for children 6 months to 18 years of age averaged 25.2% (range: 2.0%–69.1%)
and 2-dose compliance for children <9 years of age averaged 53.4% (range: 5.4%–96.2%). Factors associated with
increased coverage were non-rural site (P = 0.025), smaller office size (fewer than 5000 patients; P < 0.001), use of
evening and weekend hours to offer influenza vaccine (P = 0.004), a longer vaccination period (P = 0.014), and a
greater influenza vaccine coverage rate among office staff (P = 0.012). Increased 2-dose compliance was associated
with smaller office size (P = 0.001) and using patient reminders (P = 0.012) and negatively related to use of electronic
provider reminders to vaccinate (P = 0.003).
Conclusions: To maximize influenza vaccine coverage and compliance, offices could offer the vaccine during evening
and weekend hours, extend the duration of vaccine availability, encourage staff vaccination, and remind patients that
influenza vaccination is due. Additional efforts may be required in large offices and those in rural locations.
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In the last decade, the U.S. Advisory Committee on
Immunization Practices (ACIP) has incrementally widened
the annual influenza vaccination recommendations such
that currently, influenza vaccination is recommended
for all individuals ≥6 months [1]. As a result, uptake of
influenza vaccine among children has increased signifi-
cantly; however, U.S. vaccination rates are below target
levels of 80% [1] and disparities in coverage exist across
socioeconomic [2] and racial groups [3].
One hindrance to reaching the target influenza vaccin-
ation rates in the U.S. may be the breadth of office changes
required to vaccinate all eligible children and the magnitude* Correspondence: tnowalk@pitt.edu
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reproduction in any medium, provided the orof implementing those changes in offices across the country.
The fact that influenza vaccine is administered annually
and seasonally, rather than on an age-based schedule,
requires offices to anticipate the demand for vaccine up
to six months in advance and plan for administration
over a defined time period. Previous research has suggested
that an additional 42 to 49 million office visits would be
required to vaccinate children 5 to 18 years of age against
influenza; the burden was lower with use of a longer vac-
cination period [4]. Further complicating the situation is
the fact that first-time vaccine recipients younger than
9 years should receive two doses of influenza vaccine at
least one month apart [1].
Efficient and effective methods for vaccinating large num-
bers of children in primary care offices are essential. Previ-
ous research in this arena has been limited geographically to. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Lin et al. BMC Pediatrics 2013, 13:180 Page 2 of 5
http://www.biomedcentral.com/1471-2431/13/180one or a few offices, to offices in a localized area [5-10],
or to practices in three diverse U.S. counties [11]. The
purpose of this study was to describe influenza vaccin-
ation activities in 174 pediatric offices across the U.S. in
a variety of settings and examine the relationships of
office characteristics and those activities to influenza
vaccination coverage and two-dose compliance.
Methods
Data were collected through a prospective, observational
study conducted at outpatient pediatricians’ offices in the
U.S. during the 2008–2009, 2009–2010, and 2010–2011
influenza seasons. A central institutional review board
(Coast IRB, LLC, Lake Forest, CA; protocol MI-MA156)
approved that the study could be exempted clinical re-
search in accordance with Health Insurance Portability
and Accountability Act of 1996 (HIPAA; Public Law
104–191) privacy rules and the Code of Federal Regulations
(45 CFR §46.101). Study methods have been described pre-
viously [12,13] and are summarized below.
Inclusion criteria for primary care practices treating
children were provision of influenza vaccine at the office’s
location and the ability to generate an accurate count of
their office patient population by age. Each season, a
random sample of pediatricians from the American
Medical Association list of physicians was invited to
participate; offices from prior seasons were eligible to
continue in the study. Practices were selected to achieve
a geographically balanced sample and received limited
financial compensation for study-related data collection
and submission. Because participation in the study for
multiple years may have changed influenza vaccination
activities, data from the first season of participation for
174 offices were used for these analyses; 65 collected data
in 2008–2009, 43 in 2009–2010, and 66 in 2010–2011.
Survey information including total number of patients,
office demographics, influenza vaccine supplies, and dates
of administration was completed by a single contact in
the office at the beginning and end of the season. Twice
monthly, from August 1 through March 31, offices re-
corded in a web-based electronic database: 1) each influ-
enza vaccination administered by age group (6–23 months,
24–59 months, 5–8 years, and 9–18 years), first or second
vaccination for the child, type of vaccine (multi-dose in-
jectable, prefilled injectable, or intranasal spray), and by
payor (commercial insurance, Medicaid with Vaccines
for Children (VFC), Medicaid without VFC, self-pay);
2) office efforts to increase influenza vaccine uptake,
including verbal recommendations to patients, in-office
reading materials, posters, videotapes, letters, phone calls,
on-hold recordings, emails, and office-provided patient
incentives (e.g., toys, stickers, and coupons); 3) staff
activities (comparing patient vaccination rates among
staff, computerized vaccination reminders to staff, andeducational workshops related to influenza vaccination);
and 4) community events (school vaccination programs,
mobile vaccine clinics, clinics at other locations, and local
media coverage).
Statistical analysis
Survey data were summarized with descriptive statistics
for all offices. Coverage (proportion of children receiv-
ing ≥1 dose of influenza vaccine) and 2-dose compliance
(of the children identified as needing 2 doses, the pro-
portion who received 2 doses) were calculated. During the
2009–2010 pandemic season, only data from seasonal
influenza vaccines were assessed. Similar vaccination ac-
tivities were combined; for example, patient reminders by
voicemail, email, and mailed notices = “reminders”, and
total hours during which vaccine was offered outside of
normal office hours = “evening/weekend hours”. Univariate
analyses were performed to determine which vaccination
promotion activities were associated with influenza vaccin-
ation coverage and compliance. Linear regression analyses
for each outcome variable were performed using the office
characteristics identified a priori and those vaccination
activities with P values ≤0.10 in univariate analyses. All
independent variables were entered simultaneously. In-
fluenza season was not significantly related to either
coverage or compliance while accounting for the other
variables. Hence, data for all three years were combined
for subsequent analyses. Statistical significance was set
at alpha <0.05.
Results
Characteristics of offices participating in the study such
as location, size, staff to provider ratios, age distribution
of children, and proportion of low income children (as
indicated by participation in the VFC program) varied
widely across offices, consistent with a broad representa-
tion of offices across the country (Table 1). Likewise, there
was variability in efforts to promote influenza vaccination
and in vaccination rates. The average coverage for chil-
dren 6 months to 18 years of age was estimated at 25.2%.
Compared with patients aged 9 years and older, those
younger than 9 years had a higher coverage rate (32.2% vs.
18.6%). The 2-dose compliance for children younger than
9 years was estimated at 53.4%.
In univariate analyses (data not shown), increasing ac-
cess to influenza vaccine by extending the time vaccine
was available and offering influenza vaccination oppor-
tunities during evening and weekend hours were related
to increased vaccine coverage. Similarly, those two patient
access variables, as well as patient and provider reminders,
were significantly related to 2-dose compliance rates. In
the final linear regression analysis (Table 2), vaccination
coverage increased with increased ratio of office staff
per 1000 patients (P < 0.001), greater uptake of vaccine
Table 1 Characteristics and activities to promote
influenza vaccination of participating pediatric offices
Characteristics and activities Overall
(N = 174)
Characteristics
Total staff, mean (range) 12.6 (2–60)
Ratio of staff (Nurse + Other) to Provider
(MD + NP/PA), mean (range)
2.35 (0.14–9.00)
Total patients, mean (range) 6693 (525–36,531)
Total patient size ≥5000, n (% of offices) 85 (48.9)
Percentage of patients by age group
6–23 months, % (range) 12.5 (2.0–42.8)
24–59 months, % (range) 21.1 (5.7–41.0)
5–8 years, % (range) 22.7 (2.9–54.2)
9–18 years, % (range) 43.7 (7.5–81.2)
Staff per 1000 Patients, mean (range) 2.7 (0.4–15.2)




Percentage of Medicaid patients in office (SD) 28.3 (25.8)
Percentage of staff vaccinated (SD) 86.0 (21.7)
Activities
Number of patient reminders used:







Offer incentives (% of offices) 28.7
Family members offered vaccines (% of offices) 47.1
Number of total weekend/evening hours for
influenza vaccination, mean (SD)
7.6 (21.5)
Offered weekend/evening hours for influenza
vaccination (% of offices)
32.8
Comparison of vaccination rates within office
(% of offices)
35.6
Electronic reminders to provider to vaccinate
(% of offices)
28.2
Local immunization activities and media coverage
of influenza vaccination occurred in community
(% of offices)
54.6
Standing order program for influenza vaccine
(% of offices)
59.8
Clinical staff education workshops during influenza
season (% of offices)
22.4
Duration vaccine available, mean days (SD) 205.6 (60.8)
Coverage: % of children receiving ≥1 dose, mean (SD) 25.2 (14.9)
Table 1 Characteristics and activities to promote
influenza vaccination of participating pediatric offices
(Continued)
Coverage: % of children ≥9 years of age
receiving ≥1 dose, mean (SD)
18.6 (14.8)
Coverage: % of children <9 years of age
receiving ≥1 dose, mean (SD)
32.2 (18.8)
Compliance: % of first-time vaccinees <years of age
receiving two doses, mean (SD)
53.4 (20.0)
MD =medical doctor; NP = nurse practitioner; PA = physician assistant.
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(0.6% increase for every additional 10 days that vaccine
was offered; P = 0.014), and offering evening/weekend
hours for vaccination (P = 0.004). Larger offices (>5000
patients) and those located in rural areas had lower
influenza vaccine coverage (P < 0.05). Compliance was
lower among larger offices (P = 0.001), those with more
Medicaid-insured children, and those using electronic
provider reminders to vaccinate (P < 0.05); compliance
was higher with use of patient reminders (P = 0.012).
Discussion
The majority of childhood vaccines are given according
to an age-based schedule. This predictability allows pri-
mary care offices to develop routine office systems for
providing vaccines and scheduling well child visits. Con-
versely, providing seasonal influenza vaccines requires
an annual effort to prepare office operational systems,
remind patients and providers, order additional supplies,
and anticipate staffing needs. An office’s efforts may
range from minimal to significant office system restruc-
turing in order to accommodate its patient population,
as well as adjust to seasonal conditions such as vaccine
supply and temporal availability. The need to vaccinate
first-time vaccinees twice, separated by at least a 4-week
interval, further complicates offices’ operations during
this part of the year.
A previous study of pediatric offices in three counties
across the U.S. [11] reported that suburban location, lower
patient volume, and offering evening and/or weekend
express vaccination services were associated with higher
influenza vaccination rates among children 6 to 23 months
of age. In the present study of children 6 months to
18 years of age, similar associations were found, with
higher coverage rates among suburban/urban offices com-
pared with rural offices, those with fewer total patients,
larger staff to patient ratios, more staff who were vacci-
nated against influenza and offices that offered more
evening/weekend hours for children to receive influenza
vaccine. Having an office visit between October and
January was associated with higher vaccination rates [11];
we found that a longer duration of vaccine availability was
significantly related to higher vaccination rates. For offices
Table 2 Variables related to coverage and compliance with influenza vaccine in pediatric offices by linear regression
Explanatory variables
Coverage 2-dose compliance
Coefficient Standard error P value Coefficient Standard error P value
(Constant) 1.89 6.76 0.781 54.92 7.34 <0.001
Rural vs suburban and urban −6.21 2.75 0.025 −4.75 4.52 0.295
Office size ≥5000 patients −11.20 2.02 <0.001 −11.33 3.31 0.001
Staff/1000 patients 2.06 0.44 <0.001 −1.06 0.72 0.146
% Medicaid patients 0.03 0.04 0.450 −0.131 0.062 0.034
% Staff vaccinated 0.10 0.04 0.020 0.094 0.070 0.181
Offered weekend/evening hours for vaccination 5.92 2.03 0.004 3.87 3.45 0.264
Duration vaccine available 0.06 0.02 0.014 — — —
Patient reminders used — — — 8.66 3.39 0.012
Computer reminder to staff to vaccinate — — — −10.80 3.64 0.003
Values in boldface are statistically significant.
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extend the vaccination season beyond January to more
easily accommodate large numbers of children. Influenza
vaccination is being extended into earlier, but not later
months of the influenza season [13], but physicians have
reported that the need to administer the second dose of
vaccine for young, first-time vaccinees is an impediment
to providing late season vaccinations [14].
A recent meta-analysis of interventions to increase
influenza vaccination rates among community-dwelling
adults found that financial incentives for patients, strat-
egies for providers including audit and feedback, financial
incentives, and reminders, and system strategies such as
standing orders were most effective [15]. A qualitative
analysis of barriers and facilitators of influenza vaccination
for children suggested provider recommendation and
convenient access in which parents would not have to
miss work to have a child vaccinated, standing order
protocols, vaccination clinics, and ensuring staff support
of the vaccination effort [16]. Combined with these pre-
vious studies, our results suggest that increasing the
number of staff, especially in larger offices to: 1) handle
greater demand during influenza season; 2) cover even-
ing and weekend hours and; 3) extend the vaccination
period would enable offices to improve influenza vac-
cination coverage. Furthermore, staff support of influ-
enza vaccination demonstrated by receiving the vaccine
themselves can be an important form of provider
recommendation.
Little research has been performed on factors associated
with 2-dose influenza vaccination compliance. In an earlier
analysis of the 2010–2011 results from the current study,
Toback et al. [17] found that 2-dose compliance was
higher in smaller offices and in offices with video reminder
messages in waiting rooms. Other research among
6–23-month-old children found only visits between
October and January related to increased levels ofcompliance [11]. In the current, multi-year analysis,
higher 2-dose compliance rates were related to smaller
office size, use of patient reminders, and caring for fewer
Medicaid insured children. The types and frequency of
reminders needed to reach low income children may
differ from those for more affluent, privately insured
children. Recent studies have reported that patient re-
minders that resulted in more frequent attendance at
health care settings were associated with higher influenza
vaccination [10], and that text messaging was found to be
an effective method for reminding low income urban
children about influenza vaccination [8]. However, the
latter study did not specifically target or report 2-dose
compliance, and overall influenza vaccination coverage
remained low.
The use of computerized provider reminders to vaccin-
ate children against influenza was associated with lower
compliance rates. We have no explanation for this finding
except for anecdotal reports that providers can become
reminder-fatigued and may turn off or just ignore these
prompts, or perhaps, the electronic prompts have not
been programmed appropriately for vaccinees requiring
a second dose. Further research in this area is clearly
needed.
Strengths and limitations
One of the strengths of this study is the large number
of participating pediatric offices from across the U.S.,
presumably representing the broad spectrum of types and
location of offices as well as the assessment of a diverse
array of strategies to enhance influenza vaccination.
Although data from this study were previously analyzed
in a qualitative manner, the current analysis represents the
largest and most robust statistical analysis of office-level
factors associated with pediatric influenza vaccination.
Further, 2-dose compliance to influenza vaccination is
seldom addressed in the literature and this study examines
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vaccine uptake in children. The primary limitation is
that the offices enrolled represent a convenience sample;
their representativeness of U.S. pediatric offices overall is
unknown. Additionally, vaccination denominators and
numerators were self-reported and included only vacci-
nations given in the office; vaccinations outside of the
office were not documented. Thus, the effect of efforts
to educate and inform parents/patients may have been
underreflected in the number of in-office vaccinations
given.
Conclusions
To maximize vaccine coverage, pediatricians’ offices should
offer vaccine during evening and weekend hours and ex-
tend the duration of vaccine availability. Offices may also
be able to achieve higher influenza vaccination coverage
with a higher staff to patient ratio. Patient reminder systems
should be employed to help maximize 2-dose compliance.
Additional efforts may be required in large offices and those
in rural locations.
Consent
The observational data in this study were not collected from
patients. Hence, no consent from patients was necessary.
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